Epstein–Barr virus-associated diseases are important global health concerns. As a group I
carcinogen, EBV accounts for 1.5% of human malignances, including both epithelial-and …

Epstein–Barr virus (EBV) is a human γ-herpesvirus that infects up to 95% of the adult
population. Primary EBV infection usually occurs during childhood and is generally …

Epstein–Barr virus (EBV) infects up to 95% of the adult human population, with primary
infection typically occurring during childhood and usually asymptomatic. However, EBV can …

We have validated a flexible, high-throughput and relatively inexpensive RT-QPCR array
platform for absolute quantification of Epstein–Barr virus transcripts in different latent and …

Epstein-Barr virus (EBV) infects more than 90% of the world's adult population. Once
established, latent infection of nasopharyngeal epithelial cells with EBV is difficult to …

In recent years, Epstein‐Barr virus (EBV) lytic infection has been shown to significantly
contribute to carcinogenesis. Thus, therapies aimed at targeting the EBV lytic cycle have …

ABSTRACT BPLF1 of Epstein-Barr virus (EBV) is classified as a late lytic cycle protein but is
also found in the viral tegument, suggesting its potential involvement at both initial and late …

Cytomegalovirus (CMV) infections may increase morbidity and mortality in
immunocompromised patients. Until recently, standard antiviral drugs against CMV were …

The susceptibilities of gammaherpesviruses, including Epstein-Barr virus (EBV), Kaposi's
sarcoma-associated herpesvirus (KSHV), and animal rhadinoviruses, to various nucleoside …

Epstein–Barr virus (EBV) is a recognized oncogenic virus that is related to the occurrence of
lymphoma, nasopharyngeal carcinoma (NPC), and approximately 10% of gastric cancer …